Biotricity Inc. (BTCY) stock
BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Biotricity profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Biotricity's profit margin for the twelve months ending Jun 30, 2026 was -16.4%. For fiscal 2026 it was -15.0%, against -61.1% the year before. The highest annual figure on record is -15.0% in fiscal 2026.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -15.0% | +46.0 |
| FY2025 | Mar 31, 2025 | -61.1% | +55.8 |
| FY2024 | Mar 31, 2024 | -116.8% | +76.7 |
| FY2023 | Mar 31, 2023 | -193.6% | +187.2 |
| FY2022 | Mar 31, 2022 | -380.8% | +76.9 |
| FY2021 | Mar 31, 2021 | -457.7% | +322.9 |
| FY2020 | Mar 31, 2020 | -780.6% | +1377.1 |
| FY2019 | Mar 31, 2019 | -2157.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -22.4% | −5.1 |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -7.6% | +44.7 |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -18.0% | +16.0 |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -17.8% | +30.0 |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -17.3% | +98.0 |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -52.3% | +79.3 |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -34.0% | +60.5 |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -47.8% | +79.8 |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -115.4% | −2.4 |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -131.6% | +38.8 |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -94.5% | +89.2 |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -127.7% | +133.5 |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -113.0% | +255.4 |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -170.4% | +424.6 |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -183.7% | +136.9 |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -261.2% | +199.8 |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -368.4% | +21.2 |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -595.0% | −197.1 |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -320.6% | +378.0 |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -460.9% | +806.1 |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -389.5% | +231.3 |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -397.8% | +182.7 |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -698.6% | −59.6 |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -1267.0% | +1809.2 |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -620.8% | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -580.5% | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -639.0% | – |
| Q1 FY2019CQ2 2018 | Dec 31, 2018 | -3076.2% | – |
See a number that looks wrong?